AzTrials
AzTrials

Sonic Augmentation TechnologyNCT06902506

Exploring the Effects of Sonic Augmentation Technology in Music

A study testing Augmented Music and Non-augmented Music in people with Sonic Augmentation Technology, run by University of Florida at 1 site in United States.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

Brief Summary: It is the specific intent of this proposal to experimentally explore the possible benefits and mechanisms through which Sonic Augmentation Technology in music can influence emotional health, embodiment, and autonomic functioning. Read more about this study

Who is it for?
Ages 18 to 89 yearsHealthy volunteers can take part
Conditions the study is for
Sonic Augmentation Technology
What is being tested?
Augmented Music and Non-augmented Music
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteUnited States
Study dates
5 May 2025to 29 Aug 2027
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Between the ages of 18 and 89
  • Proficient in English

Who cannot join

  • Under the age of 18
  • Over the age of 89
  • Limited English Proficiency

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UF Health Jacksonville

    Jacksonville, Florida, 32209

Other trials in United States

About this study

Official title: Exploring the Effects of Sonic Augmentation Technology in Music on Feelings and Biobehavioral State

Brief Summary:

It is the specific intent of this proposal to experimentally explore the possible benefits and mechanisms through which Sonic Augmentation Technology in music can influence emotional health, embodiment, and autonomic functioning. The main goals of the study are:

Read more
  • To examine the immediate effects of listening to the music.
  • To identify individual characteristics that influence the effectiveness of listening to the music.
  • Phase 1 ONLY: To examine whether the participants who received the augmented theme reported more improvements than the participants who received the non-augmented theme.

Participants will be asked to attend a scheduled online Zoom meeting where they will:

  • Listen to 15-minutes of music
  • Complete a pre-music and post-music online survey
  • Phase 1 ONLY: Attend the lecture/discussion with Dr. Porges and Anthony Gorry on theory and science underlying sonic augmentation technology and the experiences it aims to evoke.
Read the detailed description

Detailed Description:

It is the specific intent of this proposal to experimentally explore the possible benefits and mechanisms through which Sonic Augmentation Technology (SAT) in music can influence emotional health, embodiment, and autonomic functioning. This will be accomplished by our team by using well-validated self-report measures of mental health and autonomic reactivity.

Specific Aims:

Specific Aim 1: To examine the immediate effects of SAT in music

•The researchers will explore whether SAT in music leads to improvements in the functioning.

Specific Aim 2: To identify individual characteristics that influence the effectiveness of listening to the music.

  • The researchers will explore the impact of specific vulnerability and resiliency factors (e.g., prior mental and medical adversity) on how well participants benefit from listening to the music.
  • The researchers will explore the impact of wearing headphones on how well participants benefit from listening to the music.

Phase 1 Experimental design:

Participants will be randomly assigned to either a Sonic Augmentation Technology-enhanced music condition or a control condition featuring the same musical theme without the enhancement. Participants will be asked to attend one virtual session via Zoom where they will:

  • Listen to 15-minutes of music
  • Complete a pre-music and post-music online survey
  • Attend the lecture/discussion with Dr. Porges and Anthony Gorry on theory and science underlying sonic augmentation technology and the experiences it aims to evoke.

Phase 2 Experimental design:

Participants will be asked to attend one virtual session via Zoom where they will:

  • Listen to 15-minutes of music
  • Complete a pre-music and post-music online survey
  • At a later date, participants will be offered the opportunity to attend an optional meeting where results will be disseminated, and Dr. Stephen Porges will be offering insights into the theory and science underlying sonic augmentation technology and the experiences it aims to evoke.
Being tested
Augmented Music, Non-augmented Music
Keywords
Polyvagal Theory, Relaxation, Autonomic Reactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Augmented MusicBehavioural

    Phase 1 \& 2: The music is augmented by embedding the natural rhythms of bodily functions (e.g. breathing, heart rate variability, vascular tone, etc) that signal the body to calm.

  • Non-augmented MusicBehavioural

    Phase 1 ONLY: Same melodic theme without the augmentation.

Study groups in NCT06902506
Study groupRoleWhat they receive
Augmented GroupExperimentalPhase 1 \& 2: Participants will first complete the pre-music survey. They will then listen to 15 minutes of augmented music. Afterward, participants will complete the post-music survey.
Receives: Behavioral: Augmented Music
Non-augmented GroupActive comparatorPhase 1 ONLY: Participants will first complete the pre-music survey. They will then listen to 15-minutes of the same musical theme without the augmentation. Afterward, participants will complete the post-music survey.
Receives: Behavioral: Non-augmented Music

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing the Impact of Autonomic Reactivity using the Body Perceptions Inventory Short Form

    This 20-item measure is scored on a 5-point Likert scale (never = 1, occasionally = 2, sometimes = 3, usually = 4, always = 5). Items are summed to determine total autonomic reactivity score, with the higher scores indicating greater autonomic reactivity

    Measured: Baseline

  2. Assessing the Impact of Adversity History

    This measure assesses the impact of six types of traumatic experiences (childhood adverse experiences, childhood maltreatment, intimate partner maltreatment, other person maltreatment, life-threatening situations, sudden losses, and person health situations). Each item is scored on a 5-point Likert scale (did not occur = 0, occurred and no impact on my life = 1 to big impact on my life = 4). Items are summed to determine total impact scores.

    Measured: Baseline

  3. Measuring Change in subjective feelings of calmness and autonomic state using the Benefits List

    This 20-item measure, which assesses subjective feelings of calmness and autonomic state was created for this study. Each item is scored on a 7-point Likert scale (0 = Not at all, 3 = Somewhat, 6 = Extremely). Higher scores on the scale generally represent increased feelings of calmness and a more balanced autonomic state.

    Measured: From baseline through study completion, an average of 65 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2025
  2. Study start5 May 2025
  3. Primary completion29 Aug 2027 (estimated)
  4. Study completion29 Aug 2027 (estimated)

Why it stopped: Keeping the study open for future recruitment.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Phase 1: Participants will be randomly assigned to the augmented or non-augmented music group. Both groups will complete an online pre-music survey. Following the 15-minutes of music, participants will complete an online post-music survey. Phase 2: Participants will complete an online pre-music survey. Then, they will listen to 15-minutes of augmented music. Following the 15-minutes of music, participants will complete an online post-music survey.
Masking
Single blind
Who is masked
Participant
Enrolment
76 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06902506
Sponsor's protocol ID
IRB202500241
Status last verified
Aug 2026
First submitted
18 Mar 2025
Last updated
8 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will not be available.

Publications

  • Dale LP, Dana AN, Lee CE, Lamont H, Van Vleet Goelz D, Dale CV, Nazarloo P, McIntosh M, Cuffe SP. Feasibility study examining the short-term effects of Sonic Augmentation Technology. Front Psychiatry. 2026 Jun 8;17:1772405. doi: 10.3389/fpsyt.2026.1772405. eCollection 2026.

    PubMed 42338740

Questions about this trial

What is this clinical trial studying?

A study testing Augmented Music and Non-augmented Music in people with Sonic Augmentation Technology, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 8 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing the Impact of Autonomic Reactivity using the Body Perceptions Inventory Short Form (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06902506, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2026; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in